Indications and uses
Temporarily relieves traveler's diarrhea diarrhea upset stomach due to overindulgence in food and drink, including: heartburn indigestion nausea gas belching fullness
Temporarily relieves traveler's diarrhea diarrhea upset stomach due to overindulgence in food and drink, including: heartburn indigestion nausea gas belching fullness
do not use more than directed chew or crush tablets completely befre swallowing do not swallow tablet whole use until diarrhea stops but not more than 2 days drink plenty of clear fluids to help prevent dehydration, which may accompany diarrhea do not exceed 16 tablets in 24 hours Adults and children: (12 years and older) Chew 2 tablets every 1/2 to 1 hour or 4 tablets every hour as needed Children under 12 year s...
Bismuth Subsalicylate 262 mg
(each tablet contains 102 mg salicylate)
Upset stomach reliever/antidiarrheal
Temporarily relieves
Reye's syndrome: Children and teenagers who have or are recovering from chicken pox or flu-like symptoms should not use this product. When using this product, if changes in behavior with nausea and vomiting occur, consult a doctor because these symptoms could be an early sign of Reye's Syndrome a rare but serious illness.
Allergy alert: Contains salicylate. Do not take if you are:
a temporary and harmless darkening of the tongue and/or stool may occur. Stool darkening should not be confused with melena.
ask a health professional before use.
In case of accidental overdose, contact a physician or poison control center immediately.
Adults and children: (12 years and older) Chew 2 tablets every 1/2 to 1 hour or 4 tablets every hour as needed
Children under 12 years: Do not give to children under 12 years of age.
acacia gum, aspartame, calcium carbonate, D&C red #27, dextrates, flavoring, magnesium stearate, maltodextrin, microcrystalline cellulose, silicon dioxide
877.506.4291
Chewable
Bismuth Tabs
Upset Stomach/Diarrhea Relief
CRANE Safety®
Bismuth Subsalicylate 262 MG
Chew or Crush Tablets Completely Before Swallowing.
Do Not Swallow Tablets Whole.
36 Tablets
Tamper Evident
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 73408-406 | 73408-406-20 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| BISMUTH SUBSALICYLATE | 62TEY51RR1 | ACTIB |
| D&C RED NO. 27 | 2LRS185U6K | IACT |
| CALCIUM CARBONATE | H0G9379FGK | IACT |
| DEXTRATES | G263MI44RU | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| SILICON DIOXIDE | ETJ7Z6XBU4 | IACT |
| ACACIA | 5C5403N26O | IACT |
| ASPARTAME | Z0H242BBR1 | IACT |
| CELLULOSE, MICROCRYSTALLINE | OP1R32D61U | IACT |
| MALTODEXTRIN | 7CVR7L4A2D | IACT |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| e221bbce-83e0-0f03-e053-2995a90abca5 | 96391d94-678b-41d7-e053-2a95a90adf33 | 2022-06-23 | Warnings | e221bbce-83e0-0f03-e053-2995a90abca5 96391d94-678b-41d7-e053-2a95a90adf33 |
Adverse event summaries are temporarily unavailable. Other product information remains available.